These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 27574007)

  • 1. Atorvastatin attenuates p‑cresyl sulfate‑induced atherogenesis and plaque instability in ApoE knockout mice.
    Han H; Chen Y; Zhu J; Ni J; Sun J; Zhang R
    Mol Med Rep; 2016 Oct; 14(4):3122-8. PubMed ID: 27574007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atorvastatin Upregulates the Expression of miR-126 in Apolipoprotein E-knockout Mice with Carotid Atherosclerotic Plaque.
    Pan X; Hou R; Ma A; Wang T; Wu M; Zhu X; Yang S; Xiao X
    Cell Mol Neurobiol; 2017 Jan; 37(1):29-36. PubMed ID: 26886754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atorvastatin attenuates atherosclerotic plaque destabilization by inhibiting endoplasmic reticulum stress in hyperhomocysteinemic mice.
    Jia F; Wu C; Chen Z; Lu G; Sun J
    Mol Med Rep; 2016 Apr; 13(4):3574-80. PubMed ID: 26956896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atorvastatin inhibits the 5-lipoxygenase pathway and expression of CCL3 to alleviate atherosclerotic lesions in atherosclerotic ApoE knockout mice.
    Yang LX; Heng XH; Guo RW; Si YK; Qi F; Zhou XB
    J Cardiovasc Pharmacol; 2013 Aug; 62(2):205-11. PubMed ID: 23615158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of atorvastatin on the expression of gamma-glutamyl transferase in aortic atherosclerotic plaques of apolipoprotein E-knockout mice.
    Li G; Wu XW; Lu WH; Ai R; Chen F; Tang ZZ
    BMC Cardiovasc Disord; 2014 Oct; 14():145. PubMed ID: 25326709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholesterol-independent effects of atorvastatin prevent cardiovascular morbidity and mortality in a mouse model of atherosclerotic plaque rupture.
    Roth L; Rombouts M; Schrijvers DM; Martinet W; De Meyer GR
    Vascul Pharmacol; 2016 May; 80():50-8. PubMed ID: 26826559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p-Cresyl sulfate promotes the formation of atherosclerotic lesions and induces plaque instability by targeting vascular smooth muscle cells.
    Han H; Chen Y; Zhu Z; Su X; Ni J; Du R; Zhang R; Jin W
    Front Med; 2016 Sep; 10(3):320-9. PubMed ID: 27527366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p-Cresyl sulfate is associated with carotid arteriosclerosis in hemodialysis patients and promotes atherogenesis in apoE-/- mice.
    Jing YJ; Ni JW; Ding FH; Fang YH; Wang XQ; Wang HB; Chen XN; Chen N; Zhan WW; Lu L; Zhang RY
    Kidney Int; 2016 Feb; 89(2):439-49. PubMed ID: 26466319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoglin as a possible marker of atorvastatin treatment benefit in atherosclerosis.
    Rathouska J; Vecerova L; Strasky Z; Slanarova M; Brcakova E; Mullerova Z; Andrys C; Micuda S; Nachtigal P
    Pharmacol Res; 2011 Jul; 64(1):53-9. PubMed ID: 21440631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rivaroxaban, a novel oral anticoagulant, attenuates atherosclerotic plaque progression and destabilization in ApoE-deficient mice.
    Hara T; Fukuda D; Tanaka K; Higashikuni Y; Hirata Y; Nishimoto S; Yagi S; Yamada H; Soeki T; Wakatsuki T; Shimabukuro M; Sata M
    Atherosclerosis; 2015 Oct; 242(2):639-46. PubMed ID: 25817329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion of the angiotensin II type 1a receptor prevents atherosclerotic plaque rupture in apolipoprotein E-/- mice.
    Aono J; Suzuki J; Iwai M; Horiuchi M; Nagai T; Nishimura K; Inoue K; Ogimoto A; Okayama H; Higaki J
    Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1453-9. PubMed ID: 22460554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic deletion of LXRα prevents arsenic-enhanced atherosclerosis, but not arsenic-altered plaque composition.
    Lemaire M; Lemarié CA; Flores Molina M; Guilbert C; Lehoux S; Mann KK
    Toxicol Sci; 2014 Dec; 142(2):477-88. PubMed ID: 25273567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the Renin-Angiotensin system mediates the effects of dietary salt intake on atherogenesis in the apolipoprotein E knockout mouse.
    Tikellis C; Pickering RJ; Tsorotes D; Huet O; Chin-Dusting J; Cooper ME; Thomas MC
    Hypertension; 2012 Jul; 60(1):98-105. PubMed ID: 22647892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MDOC and atorvastatin have potential antiinflammatory effects in vascular endothelium of apoE-/- mouse model of atherosclerosis.
    Nachtigal P; Pospisilova N; Pospechova K; Jamborova G; Kopecky M; Jaynes R; Briestensky J; Santar I; Smahelova A; Solichova D; Zdansky P; Semecky V
    Life Sci; 2006 Mar; 78(17):1983-9. PubMed ID: 16305803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of the CCR5 antagonist maraviroc in reducing early, ritonavir-induced atherogenesis and advanced plaque progression in mice.
    Cipriani S; Francisci D; Mencarelli A; Renga B; Schiaroli E; D'Amore C; Baldelli F; Fiorucci S
    Circulation; 2013 May; 127(21):2114-24. PubMed ID: 23633271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of curcumin on inhibiting atherogenesis by down-regulating lipocalin-2 expression in apolipoprotein E knockout mice.
    Wan Q; Liu ZY; Yang YP; Liu SM
    Biomed Mater Eng; 2016; 27(6):577-587. PubMed ID: 28234242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Impact of rosuvastatin on atherosclerosis lesions in apolipoprotein E knockout mice].
    Luo RN; Tao LJ; Zhou J; Wang R; Lu MM; Fu X
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Aug; 39(8):743-8. PubMed ID: 22169423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beyond Lipoprotein Receptors: Learning from Receptor Knockouts Mouse Models about New Targets for Reduction of the Atherosclerotic Plaque.
    Trusca VG; Fuior EV; Gafencu AV
    Curr Mol Med; 2015; 15(10):905-31. PubMed ID: 26592248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous intake of oat bran and atorvastatin reduces their efficacy to lower lipid levels and atherosclerosis in LDLr-/- mice.
    Eussen SR; Rompelberg CJ; Andersson KE; Klungel OH; Hellstrand P; Oste R; van Kranen H; Garssen J
    Pharmacol Res; 2011 Jul; 64(1):36-43. PubMed ID: 21371558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydrogen sulfide stabilizes atherosclerotic plaques in apolipoprotein E knockout mice.
    Xiong Q; Wang Z; Yu Y; Wen Y; Suguro R; Mao Y; Zhu YZ
    Pharmacol Res; 2019 Jun; 144():90-98. PubMed ID: 30959158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.